TGF-β blocking combined with photothermal therapy promote tumor targeted migration and long-term antitumor activity of CAR-T cells by Yuxiang Tang, WeiQi Yao, Hang Hu, Wei Xiong, Heng Mei, Yu Hu

Get full text

Plasma proteomics-based biomarkers for predicting response to mesenchymal stem cell therapy in severe COVID-19 by Tian-Tian Li, Wei-Qi Yao, Hai-Bo Dong, Ze-Rui Wang, Zi-Ying Zhang, Meng-Qi Yuan, Lei Shi, Fu-Sheng Wang

Get full text

Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trialResearch in context by Tian-Tian Li, Bo Zhang, Hui Fang, Ming Shi, Wei-Qi Yao, Yuanyuan Li, Chao Zhang, Jinwen Song, Lei Huang, Zhe Xu, Xin Yuan, Jun-Liang Fu, Cheng Zhen, Yu Zhang, Ze-Rui Wang, Zi-Ying Zhang, Meng-Qi Yuan, Tengyun Dong, Ruidan Bai, Lulu Zhao, Jianming Cai, Jinghui Dong, Jianzeng Zhang, Wei-Fen Xie, Yonggang Li, Lei Shi, Fu-Sheng Wang

Get full text

Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial by Meng-Qi Yuan, Le Song, Ze-Rui Wang, Zi-Ying Zhang, Ming Shi, Junli He, Qiong Mo, Ning Zheng, Wei-Qi Yao, Yu Zhang, Tengyun Dong, Yuanyuan Li, Chao Zhang, Jinwen Song, Lei Huang, Zhe Xu, Xin Yuan, Jun-Liang Fu, Cheng Zhen, Jianming Cai, Jinghui Dong, Jianzeng Zhang, Wei-Fen Xie, Yonggang Li, Bo Zhang, Lei Shi, Fu-Sheng Wang

Get full text

Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial by Lei Shi, Hai Huang, Xuechun Lu, Xiaoyan Yan, Xiaojing Jiang, Ruonan Xu, Siyu Wang, Chao Zhang, Xin Yuan, Zhe Xu, Lei Huang, Jun-Liang Fu, Yuanyuan Li, Yu Zhang, Wei-Qi Yao, Tianyi Liu, Jinwen Song, Liangliang Sun, Fan Yang, Xin Zhang, Bo Zhang, Ming Shi, Fanping Meng, Yanning Song, Yongpei Yu, Jiqiu Wen, Qi Li, Qing Mao, Markus Maeurer, Alimuddin Zumla, Chen Yao, Wei-Fen Xie, Fu-Sheng Wang

Get full text